Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine

Powder-injectors use gas propulsion to deposit lyophilised drug or vaccine particles in the epidermal and sub epidermal layers of the skin. We prepared dry-powder (Tg = 45.2 ± 0.5°C) microparticles (58.1 μm) of a MenY-CRM197 glyconjugate vaccine (0.5% wt.) for intradermal needle-free powder injectio...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Weissmueller, N, Marsay, L, Schiffter, H, Carlisle, R, Rollier, C, Prud'homme, R, Pollard, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Public Library of Science 2017

Παρόμοια τεκμήρια

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine.
ανά: Nikolas T Weissmueller, κ.ά.
Έκδοση: (2017-01-01)

Needle-free dermal delivery of a diphtheria toxin CRM197 mutant on potassium-doped hydroxyapatite microparticles
ανά: Weissmueller, N, κ.ά.
Έκδοση: (2015)

Intradermal powder immunization with protein-containing vaccines.
ανά: Weissmueller, N, κ.ά.
Έκδοση: (2013)

Recent advances in lipopolysaccharide-based glycoconjugate vaccines
ανά: Zhu, H, κ.ά.
Έκδοση: (2021)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
ανά: Snape, MD, κ.ά.
Έκδοση: (2009)

Needle-free vaccination: formulation and dermal delivery of diphtheria toxin CRM197 mutant
ανά: Weissmueller, NT
Έκδοση: (2013)

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
ανά: Rollier, C, κ.ά.
Έκδοση: (2014)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
ανά: Perrett, K, κ.ά.
Έκδοση: (2009)

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
ανά: Micoli, F, κ.ά.
Έκδοση: (2013)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
ανά: Snape, MD, κ.ά.
Έκδοση: (2008)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
ανά: Read, R, κ.ά.
Έκδοση: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
ανά: Read, R, κ.ά.
Έκδοση: (2014)

Meningococcal vaccines.
ανά: Rüggeberg, J, κ.ά.
Έκδοση: (2004)

Meningococcal vaccines.
ανά: Collins, C, κ.ά.
Έκδοση: (2002)

Meningococcal vaccines.
ανά: Bethell, D, κ.ά.
Έκδοση: (2002)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
ανά: Pace, D, κ.ά.
Έκδοση: (2016)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
ανά: Dold, C, κ.ά.
Έκδοση: (2023)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
ανά: Snape, MD, κ.ά.
Έκδοση: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
ανά: Snape, M, κ.ά.
Έκδοση: (2006)

Vaccines for prevention of meningococcal disease.
ανά: Pollard, A, κ.ά.
Έκδοση: (2000)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
ανά: Sachin Shivatare, κ.ά.
Έκδοση: (2022-08-01)

Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
ανά: MacLennan, C, κ.ά.
Έκδοση: (2016)

Quadrivalent meningococcal conjugate vaccines
ανά: Pace, D, κ.ά.
Έκδοση: (2009)

Quadrivalent meningococcal conjugate vaccines.
ανά: Pace, D, κ.ά.
Έκδοση: (2009)

Meningococcal disease and vaccination in North America.
ανά: Pollard, A, κ.ά.
Έκδοση: (2001)

Reconsideration of the use of meningococcal polysaccharide vaccine.
ανά: Granoff, D, κ.ά.
Έκδοση: (2007)

The epidemiology of meningococcal disease and the impact of vaccines.
ανά: Khatami, A, κ.ά.
Έκδοση: (2010)

Meningococcal polysaccharide-protein conjugate vaccines.
ανά: Snape, MD, κ.ά.
Έκδοση: (2005)

Global epidemiology of meningococcal disease and vaccine efficacy
ανά: Pollard, A
Έκδοση: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy.
ανά: Pollard, A
Έκδοση: (2004)

Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
ανά: Johanna Hettinga, κ.ά.
Έκδοση: (2020-09-01)

Vaccine prevention of meningococcal disease, coming soon?
ανά: Morley, S, κ.ά.
Έκδοση: (2001)

Vaccine prevention of meningococcal disease, coming soon?
ανά: Morley, S, κ.ά.
Έκδοση: (2001)

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial
ανά: Rollier, CS, κ.ά.
Έκδοση: (2022)

The next chapter for group B meningococcal vaccines
ανά: Wang, N, κ.ά.
Έκδοση: (2017)

Group B meningococcal vaccine science and policy
ανά: Drysdale, SB, κ.ά.
Έκδοση: (2015)

Serogroup B meningococcal vaccines-an unfinished story.
ανά: Sadarangani, M, κ.ά.
Έκδοση: (2010)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
ανά: Giuseppe Stefanetti, κ.ά.
Έκδοση: (2022-09-01)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
ανά: Robert M.F. van der Put, κ.ά.
Έκδοση: (2023-01-01)

Glycoconjugate vaccines against antimicrobial resistant pathogens
ανά: Charlotte Sorieul, κ.ά.
Έκδοση: (2023-12-01)